Use of tigecycline for treatment of serious infection due to rapidly growing Mycobacteria (especially M.abscessus)
Phase of Trial: Phase II
Latest Information Update: 25 May 2017
At a glance
- Drugs Tigecycline (Primary)
- Indications Mycobacterial infections
- Focus Therapeutic Use
- 18 May 2017 Status changed from active, no longer recruiting to completed.
- 02 Mar 2008 New trial record.